Skip to content

Clinical trials

Terminated Phase 2 Heart Failure trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 2 Status: Terminated Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20051
20064
20073
20082
20095
20104
20111
20122
20133
20152
20163
20172
20185
20191
20202
20223
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated52

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer4
AstraZeneca2
Columbia University2
Novartis Pharmaceuticals2
Adrian Hernandez1
Assistance Publique - Hôpitaux de Paris1
Barnes-Jewish Hospital1
Biogen1
Cardurion Pharmaceuticals, Inc.1
Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure52
Renal Insufficiency5
Cardiovascular Diseases4
Heart Diseases4
Cardio-Renal Syndrome2
Cardiomyopathies2
Diabetes Mellitus2
Diabetes Mellitus, Type 22
Heart Failure, Systolic2
Pulmonary Edema2

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.